1. Farrand KF, Fridman M, Ozer Stillman I, Schaumberg DA. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older. Am J Ophthalmol 2017; 182:90–98.
2. Kim M, Oh JH, Park CY, Lee SW. Dry eye disease and allergic conditions: A Korean nationwide population-based study. Am J Rhinol Allergy 2016;30(6):397–401.
3. Galor A, Feuer W, Lee DJ, et al. Depression, post-traumatic stress disorder, and dry eye syndrome: a study utilizing the national United States Veterans Affairs administrative database. Am J Ophthalmol 2012;154(2):340–346.e342.
4. Wang T-J, Wang I-J, Hu C-C, Lin H-C. Comorbidities of dry eye disease: a nationwide population-based study. Acta Ophthalmol 2012;90(7):663–668..
5. Nichols JJ, Willcox MD, Bron AJ, et al. The TFOS International Workshop on Contact Lens Discomfort: executive summary. Invest Ophthalmol Vis Sci. 2013; 54: TFOS7–TFOS13.
6. Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T, et al. The international workshop on meibomian gland dysfunction: Report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2011;52(4):2050- 64.
7. Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II Definition and Classification Report. Ocul Surf 2017;15(3): 276–283.
8. Tsubota K, Yokoi N, Shimazaki J, Watanabe H, Dogru M, Yamada M, et al. New perspectives on dry eye definition and diagnosis: A consensus report by the Asia dry eye society. The Ocular Surface 2017;15(1):65-76.
9. Baudouin C, Aragona P, Setten GV, Rolando M, Irkeç M, Benítez del Castillo J, et al. Diagnosing the severity of dry eye: A clear and practical algorithm. Br J Ophthalmol. 2014;98(9):1168-76. doi: 10.1136/bjophthalmol-2013-304619.
10. Messmer EM. The pathophysiology, diagnosis and treatment of dry eye disease. Dtsch Arztebl Int. 2015;112:71-82.
11. Milner MS, Beckman KA, Luchs JI, Allen QB, Awdeh RM, Berdahl J, et al. Dysfunctional tear syndrome: Dry eye disease and associated tear film disorders – New strategies for diagnosis and treatment. Curr Opin Ophthalmol. 2017;27:3-47. doi: 10.1097/01.icu.0000512373.81749.b7.
12. Shtein, RM., et.al. Autologous Serum-Based Eye Drops for Treatment of Ocular Surface Disease. Ophthalmology 2020;127:128-133
13. Tong L, Petznick A, Lee SY. Assessment and Management of Dry Eye Patients for Non-Ophthalmic Healtcare Practitioners. Proceedings of Singapore Healthcare.2012;Vol.21 (1).
14. Aguilar AJ, Marquez MI, Albera PA, Tredicce JL, Berra A. Effects of Systane(®) Balance on noninvasive tear film break-up time in patients with lipid deficient dry eye. Clinical Ophthalmology. 2014; 8:2365–72. [PubMed: 25473263]
15. Comez AT, Tufan HA, Kocabiyik O, Gencer B. Effects of lubricating agents with different osmolalities on tear osmolarity and other tear function tests in patients with dry eye. Current Eye Research. 2013; 38(11):1095–103. [PubMed: 23841565]
16. Simmons PA, Vehige JG. Clinical performance of a mid viscosity artificial tear for dry eye treatment. Cornea. 2007; 26(3):294–302. [PubMed: 17413956]
17. Simmons PA, Carlisle-Wilcox C, Vehige JG. Comparison of novel lipid-based eye drops with aqueous eye drops for dry eye: a multicenter, randomized controlled trial. Clinical Ophthalmology. 2015; 9:657–64. [PubMed: 25931806]
18. Pucker A D, Sueko M N, Nichols J J. Over the counter (OTC) artificial tear drops for dry eye syndrome. Cochrane Database Syst Rev. ; 2: CD009729. 2016. doi:10.1002/14651858.CD009729.pub2.
19. Li Y, Cui L, Lee HS, Kang YS, Choi W, Yoon KC. Comparison of 0.3% hypotonic and isotonic sodium hyaluronate eye drops in the treatment of experimental dry eye. Curr Eye Res. 2017;42(8):1108-14. doi: 10.1080/02713683.2017.1297462
20. Fukuoka S, Arita R. Increase in tear film lipid layer thickness after installation of 3% diquafosol ophthalmic solution in healthy human eyes. Ocul Surf. 2017;15(4):730- 5. doi: 10.1016/j.jtos.2017.03.005
Facebook 
Masuk dengan Email
